Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions

被引：3
作者：
Jeong, Young-Hoon [1 ]
Park, Yongwhi [1 ]
Kim, In-Suk [2 ]
Yun, Seong-Eun [1 ]
Kang, Min-Kyung [1 ]
Hwang, Seok-Jae [1 ]
Kwak, Choong Hwan [1 ]
Hwang, Jin-Yong [1 ]
机构：
[1] Gyeongsang Natl Univ Hosp, Div Cardiol, Dept Internal Med, Jinju 660702, South Korea
[2] Gyeongsang Natl Univ Hosp, Dept Lab Med, Jinju 660702, South Korea
来源：
THROMBOSIS AND HAEMOSTASIS | 2010年 / 104卷 / 06期
关键词：
PERCUTANEOUS CORONARY INTERVENTION; CLOPIDOGREL; THROMBOSIS; AGGREGATION; FUTURE;
D O I：
10.1160/TH10-04-0239
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1286 / 1289
页数：4
相关论文
共 50 条
  • [31] Addition of Cilostazol to Conventional Dual Antiplatelet Therapy Reduces the Risk of Cardiac Events and Restenosis After Drug-Eluting Stent Implantation: A Meta-Analysis
    Chen, Zhangwei
    Qian, Juying
    Chen, Yinghua
    Ma, Jianying
    Ge, Junbo
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (05) : 532 - 539
  • [32] The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
    Hu, Mengjin
    Gao, Xiaojin
    Yang, Jingang
    Yang, Yuejin
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [33] Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation
    Lee, Seung-Jun
    Cha, Jung-Joon
    Jeong, Young-Hoon
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Jung-Sun
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Loo, Hyung Joon
    Chang, Kiyuk
    Park, Yongwhi
    Bin Song, Young
    Ahn, Sung Gyun
    Suh, Jung-Won
    Lee, Sang Yup
    Cho, Jung Rae
    Her, Ae-Young
    Kim, Hyo-Soo
    Kim, Moo Hyun
    Shin, Eun-Seok
    Lim, Do-Sun
    Kim, Byeong-Keuk
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (22) : 2253 - 2265
  • [34] Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)
    Lee, Seung-Whan
    Park, Seong-Wook
    Yun, Sung-Cheol
    Kim, Young-Hak
    Park, Duk-Woo
    Kim, Won-Jang
    Lee, Jong-Young
    Lee, Cheol Whan
    Hong, Myeong-Ki
    Kim, Jae-Joong
    Park, Seung-Jung
    AMERICAN HEART JOURNAL, 2010, 159 (02) : 284 - 291.e1
  • [35] Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials
    Barbarawi, Mahmoud
    Kheiri, Babikir
    Zayed, Yazan
    Aburahma, Ahmed
    Osman, Mohammed
    Barbarawi, Owais
    Hicks, Michael
    Hassan, Mustafa
    Alkotob, Mohammad L.
    Bachuwa, Ghassan
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2019, 9 (01): : 9 - 17
  • [36] Less may be more: Insights on dual antiplatelet therapy duration after drug-eluting stent implantation from the MATRIX registry
    Klein, Andrew J.
    Brilakis, Emmanouil S.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 80 (03) : 417 - 419
  • [37] Dual antiplatelet therapy following drug-eluting stent implantation: how long is long enough?
    Ruparelia, Neil
    Chieffo, Alaide
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (06) : 585 - 587
  • [38] Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation
    Yan, Bryan P.
    Gurvitch, Ronen
    Ajani, Andrew E.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2006, 7 (03) : 155 - 158
  • [39] Individualized antiplatelet therapy after drug-eluting stent deployment: Implication of clinical trials of different durations of dual antiplatelet therapy
    Nakamura, Masato
    Kougame, Norihiro
    Iijima, Raisuke
    Ono, Tsuyoshi
    Ikeda, Nobutaka
    Tokue, Masahide
    Hayashi, Fumiyuki
    Watanabe, Mami
    Takenaka, Hiroki
    Fukui, Ryo
    Hara, Hidehiko
    JOURNAL OF CARDIOLOGY, 2017, 70 (5-6) : 511 - 517
  • [40] Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
    Mauri, Laura
    Kereiakes, Dean J.
    Yeh, Robert W.
    Driscoll-Shempp, Priscilla
    Cutlip, Donald E.
    Steg, P. Gabriel
    Normand, Sharon-Lise T.
    Braunwald, Eugene
    Wiviott, Stephen D.
    Cohen, David J.
    Holmes, David R., Jr.
    Krucoff, Mitchell W.
    Hermiller, James
    Dauerman, Harold L.
    Simon, Daniel I.
    Kandzari, David E.
    Garratt, Kirk N.
    Lee, David P.
    Pow, Thomas K.
    Lee, Peter Ver
    Rinaldi, Michael J.
    Massaro, Joseph M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (23) : 2155 - 2166
12345